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ERCP IN EVALUATING THE MODE OF THERAPY IN
PANCREATIC PSEUDOCYST
I. NORDBACK*, O. AUVINEN, I. AIRO, J. ISOLAURI and O. TEERENHOVI
Department ofSurgery, University Central Hospital, Tampere, Finland
Twenty patients with ultrasonographic or computed tomographic diagnosis of pancreatic pseudocyst were
referred for endoscopic retrograde cholangiopancreatography (ERCP). Two of these were found at
laparotomy not to have pseudocysts and were excluded. Pancreatography was successful in 15 out of 18
cases (83%) and cholangiography in 12 out of 18 cases (67%). Three types of pseudocysts were noticed
according to the communication of the pseudocyst to the main pancreatic duct and the presence of
pancreatic duct stensosis. Successful treatment included two spontaneous resolutions, two internal
drainages and three left pancreatic resections. In the eight percutaneous external drainages four
recurrences (50%) occurred, one after closure of temporary pancreatocutaneous fistula. All the
recurrences occurred in Type III pseudocysts with communication of the pseudocysts to stenotic main
pancreatic duct. In these cases internal drainage would have been the preferable treatment method. We
believe that by ERCP one can identify pseudocysts not suitable for external drainage.
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INTRODUCTION
Pancreatic pseudocysts are classified as acute or chronic depending on whether they
developed immediately after acute pancreatitis1. The time interval between the
onset of acute pancreatitis and discovery of pseudocysts has been 1-6 weeks, while in
patients with chronic symptomatic pseudocysts no episode of acute pancreatitis can
be found. Most pseudocysts are acute (40-75%) with a spontaneous resolution
frequency up to 400/02, whereas 25-60% are chronic pseudocysts with a minimal
(3%) spontaneous resolution rate3. Because of the considerable complication rate,
active management has been recommended for pseudocvsts over 4cm in diameter4.
Endoscopic retrograde cholangiopancreatography (ERCP) has been considered a
valuable investigation method in planning the therapy of pseudocysts. The
advantage of ERCP is the demonstration of the exact location and possible
multiplicity of pseudocysts, and ductal anatomy and pathology in relation to the
pseudocyst, as well as simultaneous biliary abnormalities5-8. It has been claimed that
the pre-operativeERCP may modify tactics in 50% of patientsv. Thus, better therapy
results may be expected. Hence, we have here analyzed our experience ofERCP in
pancreatic pseudocysts.
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METHODS
Between February 1984 and June 1987 ERCP was performed on 20 patients with
suspected pseudocyst of the pancreas. At laparotomy one of these was found to be a
mucinous cystadenoma of the pancreas and another pancreatic carcinoma and
splenic cyst. Both cases were excluded. Three of the remaining ERCPs failed, twice
due to duodenal compression caused by the pseudocyst and once due to technical
failure in cannulation. Thus, the study material comprises 15 patients.
In all cases abdominal ultrasonography was performed. By this means pseudocyst
was revealed in 10 cases, abdominal CT gave the diagnosis in four further cases, and
in one case pseudocyst was not diagnosed until ERCP. The size of the pseudocyst
varied from 2 to 15 cm (mean 7 cm; in four cases below 4 cm).
The ERCPs were performed by an Olympus JF IT 10 side-viewing duodenoscope.
The patients were lying on their left in a prone position. The pancreatic duct was
cannulated selectively in all cases. Common bile-duct cannulation was attempted but
failed in three cases. A single dose of netilmycin (150 mg) and more recently (last
seven cases) ceftazidime (1 g) was given intravenously immediately prior to ERCP.
In cases with pseudocyst filling the drug was continued for three days. Diazepam (10
mg intravenously) was used for sedation, and glucagon (0.3 mg intravenously) or
butylscopolamine (20 mg intravenously) for inhibiting duodenal peristalsis. The
contrast medium was injected gently through sterile catheters under fluoroscopic
control. The injection was discontinued when secondary side branches of the
pancreatic ,duct or pseudocyst started to fill.
The mean time interval between ERCP and pseudocyst therapy was 13 days. The
therapeutic approach was undertaken within 48 h in six cases. Table 1 shows data of
the patients and pseudocysts.
The relation between ductal anatomy and,pseudocyst was classified (Figure 1),
modifying that presented by Sugava and Walt\ In type I the main pancreatic duct is
imaged up to the end without much stenosis. The pseudocyst may (Type IA) or may
not (IB) be filled, but is further away from the main pancreatic duct. In Type II there
is again no main duct stenosis and pseudocyst opens to the duct. In Type III there is
Table 1 Patients treated for pancreatic pseudocysts with preceding ERCP.
Number of cases
Mean age (range)
Sex
Men
Pseudocysts
Acute
Chronic
Aetiology
Alcohol
Biliary
Other or unknown
Mean follow-up (range)
15
50 years (34-80)
11(73%)
4(27%)
3(20%)
12(80%)
9(60%)
4(27%)
2(13%)
8 months (2 months- 3 years)ERCP IN PANCREATIC PSEUDOCYST 37
A
type type II type III
Figure 1 Classification of pseudocysts according to the communication of the pseudocysts to the main
pancreatic duct (Types II and IIIA, possibly Type IIIB) and the presence of stenosis in the main duct
(Type III).
stenosis of the main pancreatic duct. There may again be filling of the pseudocyst
behind the stenosis (IIIA), or not (IIIB). Pancreatograms of various types are
presented in Figures 2-6.
Possible ERCP complications were investigated. The method of treatment and its
complications were recorded. The resolution and possible recurrence of the
pseudocyst were checked by ultrasonographic follow-up.
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Figure 3 Pancreatography of Type IB with severe chronic pancreatitis.
RESULTS
The success rate in access of the pancreatic duct was 15 out of 18 cases (83%), with
only one technical failure in cannulation (1/18 6%). The respective success rate in
selective bil-duct cannulation was 12 out of 18 cases (67%), with four technical
failures (22%).
The pseudocysts were distributed into various types as shown in Table 2. Over half
(8/15) had main duct stenosis between the pseudocyst and papillary orifice.
Table 2 Distribution of patients with pancreatic pseudocysts according to our classification presented
in Figure 1.
Acutepseudocysts Chronicpseudocysts
Type A
B 2
Type II 2 2
Type III A 4
B 4ERCP IN PANCREATIC PSEUDOCYST 39
Figure 4 Pancreatography of Type II.
The distribution of the method of therapy is shown in Table 3. Combined external-
internal drainage was performed by percutaneous transgastric drainage of the
pseudocyst with side-holes of the catheter in the stomach. However, no initial
decrease in pseudocyst size was observed upon keeping the catheter closed for
external drainage. It was thereafter opened, and started to work. Therefore the case
is here classified in the group of external drainage.
No haemorrhagic or septic complications occurred. One patient developed
pancreatocutaneous fistula after percutaneous external drainage. The fistula closed
spontaneously but recurrent pseudocyst soon followed. Three further pseudocyst
recurrences took place. Total recurrence incidence was 27%.
Table 4 shows the success of therapy according to ERCP classification. Two cases
with Type II patho-anatomy were managed expectantly and resolution occurred
spontaneously in both cases in 8 and 12 weeks, respectively. All the recurrences
occurred in external drainage in Type III pseudocysts. One of these recurrences was40 I. NORDBACK, O. AUVINEN, I. AIRO, J. ISOLAURI and O. TEERENHOVI
Table 3 Methods of primary therapy of pancreatic pseudocysts.
Expectant
External drainage
Internal drainage
gastric
duodenal
jejunal
Combined internal-external
Pancreatic resection
Table 4 Pseudocyst recurrences according to therapy and ERCP classification.
2(13%)
7(47%)
2(13%)
1(7%)
3(20%)
Type Expectant External drainage Internal drainage Resection
n Recurrences n Recurrences n Recurrences n Recurrences
3 0
II 2 0 0 0
III 5 4 0 2 0
Figure 5 Pancreatography of Type IIIAoERCP IN PANCREATIC PSEUDOCYST 41
Figure 6 Pancreatography of Type IIIB.
treated with left pancreatic resection and another with pseudocystojejunostomy,
both successfully. The remaining two recurrences are at present under further
estimation for treatment.
In the 12 cholangiograms gall-bladder stones were found once. In another case an
"open" papillary orifice was seen in duodenoscopy, giving suggestion of a "passed
stone"; in biliary radiography no further abnormalities were found.
ERCP-related complications such as septicaemia, acute phase pancreatitis,
cholangitis etc. were never found.
DISCUSSION
The total number of pancreatic pseudocysts treated in our hospital in the study
period was 19; ERCP was attempted on 18 of these. The success rates of
pancreatography and cholangiography in patients with pancreatic pseudocysts have
o7 06 been reported to be 80-90 Vo and around 70 Vo respectively. The present figures
(83%, 67%) can be considered comparable. The lower figure of bile-duct
cannulation success is possibly due to lower enthusiasm for bile-tract pathology in
cases with alcoholic aetiology of the disease.
Since Amman’s first report
9 of a fatal ERCP complication in a patient with
pancreatic pseudocyst, caution has been recommended in performing retrograde
pancreatograms in this situation. However, in a recent series of 83 ERCPs for
pseudocysts, transient pyrexia was the only complication5. In another series a 4%42 I. NORDBACK, O. AUVINEN, I. AIRO, J. ISOLAURI and O. TEERENHOVI
sepsis frequency was noted (two patients)7; the sepsis occurred only if there was a
delay in pseudocyst therapy. That 4% is, however, only slightly more than the
percentage reported in all ERCP examinations. We had no ERCP complications
independent of the delay in pseudocyst therapy in half of the cases. Thus, ERCP can
be considered a safe procedure in patients with pseudocysts. The need for immediate
7 therapeutic intervention upon the pseudocyst after ERCP may be held to be
questionable5.
ERCP has been considered important in pseudocyst patients for the investigation
of the biliary tract3. Biliary pathology has been reported in over half of these cases7.
The smaller frequency (17%) of biliary pathology here may be due to the
overwhelming preponderance of alcohol aetiology.
After the introduction of percutaneous needle aspirations’2 and percutaneous
external drainage
13 of pseudocysts we became enthusiasts about this kind of therapy,
which is minimally burdensome to the patient. The results in these reports were
surprisingly good in the light of the 24-36% pseudocyst recurrence rate after surgical
14 16 external drainage More recently, less encouraging results have been published,
with a recurrence rate of up to 47/o 8’7. Here, the respective figure was 50%.
All the present recurrences (one with preceding fistula) occurred in the external
drainage group. Moreover, all fell into the Type III category. It may easily be
imagined that the pancreas behind the ductal stenosis is secreting towards the
pseudocyst. If a canal is opened from the pseudocyst, the secretion continues into
the intestinal canal in cases of internal drainage and outside the body in the form of
pancreatic fistula in the cases of external drainage. Closure of the internal or external
fistula is then followed by recurrent pseudocyst without recurrence after external
drainage. This pseudocyst was very caudal, rather a juxtasplenic pseudocyst with
stenosis just at the orifice of the pseudocyst. Thus, the pseudocyst hardly collected
any true pancreatic secretes, and could also have been classified in the Type IA
category.
Communication of the pseudocyst to the main pancreatic duct has been earlier
proposed to be the cause of failure of external pseudocyst drainageTM, although the
condition has been considered rarea3,a8. We found clear ductal communication in
eight out of 15 cases (53%; Types II and IIIA). Moreover, in Type IIIB
communication is also very possible.
We found only anecdotal comments on the importance of ductal strictures in the
planning of surgical operations for pseudocysts’6. However, it is standard practice to
perform ductography to reveal ductectasiae and ductal strictures when treating
chronic pancreatitis operatively9. Therefore, it is equally logical to consider
pancreatography important in evaluating the method of treatment. This may be
performed percutaneously through a pseudocyst puncture or by retrograde
endoscopically. We prefer the latter method because it also provides the possibility
of examining the biliary tract and shows pancreatic ductal anatomy in the case of non-
communicating pseudocysts.
Four of the pseudocysts were 4 cm or less in diameter. Two resolved spontaneously
(both Type II) and two were successfully drained externally (Type IB). Small
pseudocysts have been said to tend to resolve spontaneously2. It could also be
claimed that, in cases without clear communication to the main duct (Type I), or with
ductal communication but without ductal stenosis (Type II), large pseudocysts are
rare, and part of them (Type II) tends to resolve spontaneously by drainage through
the pancreatic duct into the duodenum. Here, the pseudocyst size in Types I and IIERCP IN PANCREATIC PSEUDOCYST 43
was 4.5 cm on average, as compared to 9.5 cm in Type III.
In acute pseudocysts the immature cyst wall prevents secure internal drainage16’2.
Percutaneous external drainage may be performed in cases with rapid enlargement
or infection. ERCP, however, may again be called for in cases with suspected biliary
pathology. In the three acute pseudocysts studied here, ERCPs visualized the
gallstones once.
In conclusion, chronic pseudocysts as well as acute pseudocysts after 6 weeks’
follow-up, and without marks of spontaneous resolution, can be safely examined by
ERCP. We suppose that in Type I pseudocysts external drainage (percutaneous)
should suffice as treatment. In Type II pseudocysts, spontaneous resolution may
occur and expectant management is recommended for 12 weeks. Cases with still-
persisting pseudocyst as well as those falling in the Type III category should be
treated with internal drainage to the stomach (possibly endoscopically or
percutaneously)21-23, duodenum or jejunum, depending on the location. In Type III
pseudocysts, caudal resection right of the ductal stenosis is recommended in cases
with technical possibilities because closure of the pseudocysto-enterostomy might be
followed by a recurrent pseudocyst. If the surgeon still remains aware ot the
possibility of multilocated and multiple pseudocysts, a very small recurrence rate
may be expected.
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